Satori Pharmaceuticals
Cambridge, US
Founders & leadership
JI
Jeffrey IvesExecutive
Board
DS
David SchnellBoard director
CE
Chris EhrlichBoard director
EM
Edward MathersBoard director
SM
Stephen MunizBoard director
BS
Bennett ShapiroBoard director
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2012
▶$15MraisedFeb 2012 · PharmaceuticalsRule 506(b)
▶$15MraisedFeb 2012 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bennett ShapiroDirector
- Jeffrey IvesExecutive Officer, Director
- David SchnellDirector
- Chris EhrlichDirector
- Edward MathersDirector
- Stephen MunizDirector
- Offering amount
- $19.2M
- Amount sold
- $15M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Satori Pharmaceuticals raised?
- Satori Pharmaceuticals has disclosed $15M raised across 1 round.
- Where is Satori Pharmaceuticals headquartered?
- Satori Pharmaceuticals is headquartered in Cambridge, US.